Document Mentions (3 shared documents)

EFTA00135712

2 mentions1 same-page

Page ?Same page

lding; 10:00 AM • House Small Business subcommittee hybrid hearing on 'Preventing Fraud and Abuse of PPP and EIDL - Investigations, Oversight, and Regulations Subcommittee hybrid hearing on 'Preventing Fraud and Abuse of PPP and EIDL: An Update with the SBA Office of Inspector General and the Government Accountability

ustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human Rights Commission v

EFTA00148896

2 mentions1 same-page

Page ?Same page

ing; 10:00 AM • House Small Business subcommittee hybrid hearing on 'Preventing Fraud and Abuse of PPP and EIDL' - Investigations, Oversight, and Regulations Subcommittee hybrid hearing on 'Preventing Fraud and Abuse of PPP and EIDL: An Update with the SBA Office of Inspector General and the Government Accountability

nsustainable drug prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human Rights Commission v

EFTA01658495

2 mentions1 same-page

Page ?Same page

ing; 10:00 AM • House Small Business subcommittee hybrid hearing on 'Preventing Fraud and Abuse of PPP and EIDL' - Investigations, Oversight, and Regulations Subcommittee hybrid hearing on EFTA01658535 'Preventing Fraud and Abuse of PPP and EIDL: An Update with the SBA Office of Inspector General and the Government

Mutual Connections (893)

Entities connected to both Regulations Subcommittee and Robert Bradway

Quinton Lucas